There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is
superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted
a randomized trial comparing the two methods.